| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/22/2013 | CN102441132B Traditional Chinese medicine stone expelling soup for treating urinary calculus |
| 05/22/2013 | CN102204995B Kidney-reinforcing tonic wine |
| 05/22/2013 | CN101903359B Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists |
| 05/22/2013 | CN101862331B New use of methyl liensinine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/21/2013 | US8445694 Hydrazonopyrazole derivatives and their use as therapeutics |
| 05/21/2013 | US8445011 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2397987C Use of at least a fatty ester for preparing a composition designed to inhibit 5 alpha reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 05/21/2013 | CA2294865C Immunogenic lhrh compositions and methods relating thereto |
| 05/18/2013 | CA2795893A1 Controlled release formulations of tolterodine and process of manufacturing |
| 05/16/2013 | WO2013071262A1 Calcimimetics and methods for their use |
| 05/16/2013 | WO2013068836A1 A ddr1 antagonist or an inhibitor of ddr1 gene expression for use in the prevention or treatment of crescentic glomerulonephritis |
| 05/16/2013 | WO2013068776A1 Combination of active ingredients for the treatment of acute kidney injury |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/16/2013 | CA2854911A1 Calcimimetics and methods for their use |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2592070A2 Tetrazole-substituted arylamides |
| 05/15/2013 | EP2591797A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 05/15/2013 | EP2591784A1 Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system |
| 05/15/2013 | EP2590985A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 05/15/2013 | EP2590973A1 Solifenacin salts |
| 05/15/2013 | EP2590658A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/15/2013 | CN103108882A Polycrystalline type object of CDDO BIEA and use thereof |
| 05/15/2013 | CN103103081A Medicinal wine for tonifying kidney and nourishing liver |
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103100071A Pill used for treating kidney deficiency and diuresis |
| 05/15/2013 | CN103100046A Traditional Chinese medicine for treating chyluria by utilizing common adenostema herb |
| 05/15/2013 | CN103100041A Traditional Chinese medicine preparation for treating qi stranguria |
| 05/15/2013 | CN103099998A Traditional Chinese medicine decoction for treating diabetic nephropathy |
| 05/15/2013 | CN103099941A Traditional Chinese medicine oral liquid and preparation method thereof |
| 05/15/2013 | CN103099895A Preparation method of medicinal liquor for treating middle-aged and old frequent urination |
| 05/15/2013 | CN103099891A Preparation method of belladonna extract |
| 05/15/2013 | CN103099870A Turtle shell capsules for resolving hard lump |
| 05/15/2013 | CN103099850A Application of nymphaea hybrid or product thereof |
| 05/15/2013 | CN103099788A Traditional Chinese medicine composite decoration from powder, preparation and decoction methods and dosage relation thereof |
| 05/15/2013 | CN103099780A Preparation method of hydrogen-microbubble-containing aqueous solution, and product and application of method |
| 05/15/2013 | CN102872115B Application of Houttuynoid A in preparing medicament for treating acute renal failure |
| 05/15/2013 | CN102579706B Traditional Chinese medicine for treating urinary stone |
| 05/15/2013 | CN102526614B Chinese medicinal kidney healing powder for treating chronic renal failure |
| 05/15/2013 | CN102443528B Wolfberry yam wine and preparation method thereof |
| 05/15/2013 | CN102302716B Oral traditional Chinese preparation for treating nephritis |
| 05/15/2013 | CN102302707B Philippine flemingia kidney meprobamate pharmaceutical composition, production method thereof, and preparation thereof |
| 05/15/2013 | CN102283841B Application of N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide in preparation of medicine for treating kidney disease |
| 05/15/2013 | CN101889996B Rectal administration composition containing tamsulosin |
| 05/15/2013 | CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440228 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2560927C Insulin resistance-improving agent |
| 05/14/2013 | CA2521217C Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 05/14/2013 | CA2441562C Short bioactive peptides and methods for their use |
| 05/10/2013 | WO2013067420A1 Acth for treatment of kidney disease |
| 05/10/2013 | WO2013067248A1 Benzoxazines as modulators of ion channels |
| 05/10/2013 | WO2013066795A1 Stable pharmaceutical formulations of growth factor peptides |
| 05/10/2013 | WO2013064467A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase |
| 05/10/2013 | WO2013044356A9 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 05/10/2013 | WO2012124311A8 Novel phenylpyridine derivative and drug containing same |
| 05/10/2013 | CA2848824A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/08/2013 | EP2589382A1 Pharmaceutical composition comprising levocarnitine and dobesilate |
| 05/08/2013 | EP2588479A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 05/08/2013 | EP2588196A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/08/2013 | CN103097393A Quinoxaline compound |
| 05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 05/08/2013 | CN103097391A Novel spiroheterocyclic compounds as mGlu5 antagonists |
| 05/08/2013 | CN103097383A Pyrazoloquinoline compound |
| 05/08/2013 | CN103096903A The therapeutic use of tetrathiomolybdate |
| 05/08/2013 | CN103087884A Preparation method of ginseng and Chinese date tonic wine for invigorating spleen, supplementing qi and tonifying kidney |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087050A Aryl kinase inhibitor |
| 05/08/2013 | CN103083679A Preparation method of lysozyme curcumin nanoparticle |
| 05/08/2013 | CN103083670A Application of inhibiting agent of cathepsin K |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083617A Traditional Chinese medicine for treating hyperplasia of prostate |
| 05/08/2013 | CN103083610A Chronic glomerulonephritis treatment drug |
| 05/08/2013 | CN103083607A Traditional Chinese medicine composition for treating chronic renal insufficiency |
| 05/08/2013 | CN103083604A Essence boosting and kidney tonifying soup |
| 05/08/2013 | CN103083603A pharmaceutical composition with functions of intelligence benefiting and kidney warming and preparation method thereof |
| 05/08/2013 | CN103083563A Preparation method for traditional Chinese medicine prescription capable of treating anaphylatic purpura nephritis |
| 05/08/2013 | CN103083553A Kidney relieving pharmaceutical composition and preparation method thereof |
| 05/08/2013 | CN103083523A Traditional Chinese medicine composition for treating chronic prostatitis and preparation method of composition |
| 05/08/2013 | CN103083501A Soft capsule preparation for preventing and treating diseases of old people |
| 05/08/2013 | CN103083452A Traditional Chinese medicine for treating chronic bacterial prostatitis |
| 05/08/2013 | CN103083440A Multi-functional natural healthcare product |
| 05/08/2013 | CN103083434A Yang warming and blood activating traditional Chinese compound preparation for preventing and treating chronic kidney diseases and application thereof |
| 05/08/2013 | CN103083417A Medicine composition for treating chronic uremia and preparation method thereof |
| 05/08/2013 | CN103083413A Traditional Chinese medicine composition patch for detoxifying and protecting kidney |
| 05/08/2013 | CN103083398A Drug for treating chronic nephritis and preparation method of drug |
| 05/08/2013 | CN103083386A Medicine comosition for treating chronic nephritis and preparation method thereof |
| 05/08/2013 | CN103083328A Preparation method of rape bee pollen long chain fatty acids and derivatives thereof |
| 05/08/2013 | CN103083318A Bilayer tablet comprising telmisartan and amlodipine |